Drawing for Serial No. 88331405

USPTO serial 88331405

Serial No. 88331405

Reviewed by CopyMark Law Group

Reg. 6021836Status 710
Filing date
Status date
Registration date
Mar 31, 2020
Examiner
CROWDER-SCHAEFER, ANDREW W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 88331405?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Allison Strickland Ricketts

Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment of respiratory, inflammatory, and fibrotic diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of respiratory, inflammatory, and fibrotic diseases, disorders and conditionsSECTION 8 - CANCELLED—
042Scientific and technological services, namely, medical research and scientific research, chemical analysis in the healthcare and biomedical fields; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market pharmaceutical and biologic trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market pharmaceutical and biologic trialsSECTION 8 - CANCELLED—
044Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditionsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026C8..CANCELLED SEC. 8 (6-YR)—
Mar 31, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 6, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 31, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 10, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 10, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 10, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 24, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 24, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2019DOCKASSIGNED TO EXAMINER—
Mar 28, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 27, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 12, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance